Sales rise 89.57% to Rs 60.00 crore
Net profit of Jagsonpal Pharmaceuticals rose 171.83% to Rs 6.85 crore in the quarter ended June 2021 as against Rs 2.52 crore during the previous quarter ended June 2020. Sales rose 89.57% to Rs 60.00 crore in the quarter ended June 2021 as against Rs 31.65 crore during the previous quarter ended June 2020. ParticularsQuarter EndedJun. 2021Jun. 2020% Var.Sales60.0031.65 90 OPM %15.478.37 -PBDT9.993.30 203 PBT9.713.03 220 NP6.852.52 172Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
